(Q46340885)

English

Antibodies to myelin oligodendrocyte glycoprotein are not involved in the severity of chronic non-remitting experimental autoimmune encephalomyelitis

scientific article published on 29 September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

Antibodies to myelin oligodendrocyte glycoprotein are not involved in the severity of chronic non-remitting experimental autoimmune encephalomyelitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

oligodendrocyte

1 reference

based on heuristic

inferred from title

7

object named as

Tasuku Honjo

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

Masamichi Muramatsu

6

object named as

Masamichi Muramatsu

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

author name string

Yukio Sekiguchi

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

Motoki Ichikawa

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

Masaya Takamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

Hiroyoshi Ota

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

Chang-Sung Koh

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

Kazunaga Agematsu

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

publication date

29 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

immunology Letters

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

122

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

145-149

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Unmutated immunoglobulin M can protect mice from death by influenza virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Discovery of activation-induced cytidine deaminase, the engraver of antibody memory

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Encephalitogenic activity of truncated myelin oligodendrocyte glycoprotein (MOG) peptides and their recognition by CD8+ MOG-specific T cells on oligomeric MHC class I molecules

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

B cells regulate autoimmunity by provision of IL-10.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

B cells and antibodies in CNS demyelinating disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Brain-derived gangliosides suppress the chronic relapsing-remitting experimental autoimmune encephalomyelitis in NOD mice induced with myelin oligodendrocyte glycoprotein peptide

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Late complications of immune deviation therapy in a nonhuman primate

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Increased severity of experimental allergic encephalomyelitis in lyn-/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

T cell line-mediated EAE: prevention and therapy by a monoclonal antibody specific for T lymphoblasts

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Protection of research subjects

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

The different process of class switching and somatic hypermutation; a novel analysis by CD27(-) naive B cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IMLET.2008.08.009

Identifiers

10.1016/J.IMLET.2008.08.009

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824198

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46340885&oldid=2106384170"